mhdo.maine.govMHDO Home Page

Skip to Content Home Data Contact Security and Privacy CompareMaine Maine Quality Forum APCD Portal Hospital Data Portal Data Request Portal Prescription Drug Price Portal Administrative MHDO Board Meetings Data Release Subcommittee MHDO Value Proposition Subcommittee Rules and Statutes CompareMaine CompareMaine.Org Facility and Payor Resources Interactive Reports Data Availability Hospital Dashboard Physician Dashboard Prescription Drug Reports Healthcare Procedure Cost Drivers Obtain Data Request Data or Reports Pricing Information Release Schedule Public Posting of Requests FAQs Data Submitters Claims Data Hospital Data Financial Data Hospital Quality Data Info for Data Users APCD Hospital Encounters Hospital Financials Hospital Quality Data Reports User Groups Consumer User Group Data User Group HAI Collaborating Partners Committee Reporting External Reports SIM Core Metrics Dashboard Updates Agency Transformation News 2020 Upcoming Events Improving our website is part of our transformation. Check back often to see our updates! MHDO is a state agency that collects health care data and makes those data available to researchers, policy makers, and the public while protecting individual privacy. The purpose of the organization is to create and maintain a useful, objective, reliable and comprehensive health information database that is used to improve the health of Maine citizens. Learn More Recent Announcements June 9, 2020 - Proposed Rule Chapter 100 - Enforcement Procedures Has Been Adopted This rule was adopted and is effective as of July 3, 2020. March 19, 2020 - Rule Chapter 300 - Uniform Reporting System for Hospital Financial Data Has Been Adopted This rule was adopted and is effective as of March 16, 2020. February 6, 2020 - Rule Chapter 570 - Uniform Reporting System for Prescription Drug Price Data Sets Has Been Adopted This rule was adopted and is effective as of February 4, 2020. February 6, 2020 - Rule Chapter 10 - Determination of Assessments Has Been Adopted This rule was adopted and is effective as of February 4, 2020. January 2020 - New Report Public Law, Chapter 244, requires the Maine Quality Forum to develop an annual report beginning January 15, 2020 on primary care spending using claims data from the Maine Health Data Organization. The report must also include information on the methods used to reimburse primary care providers from payers. Here is the first annual report . January 2, 2020 - Proposed Rule Chapters 241 and 243 were Adopted and are Now Effective The proposed Rule Chapter 241 - Uniform Reporting System for Hospital Inpatient Data Sets and Hospital Outpatient Data Sets and proposed Rule Chapter 243 - Uniform Reporting System for Health Care Claims Data Sets were adopted and each is effective December 22, 2019. December 11, 2019 - 2018 Hospital Financial Reports Now Available Annual Summary Reports of hospital financial data over a five year period (FY 2014-2018) as reported by Maine hospitals including information on profitability, liquidity, capital structure and other common financial ratios are now available. October 30, 2019 - Proposed Rule Chapter 570 - Uniform Reporting System for Prescription Drug Price Data Sets PL 2019, c 470, “An Act to Further Expand Drug Price Transparency” requires prescription drug manufacturers to report to the Maine Health Data Organization no later than January 30, 2020 and annually thereafter, on prescription drug prices when the manufacturer has during the prior calendar year increased the wholesale acquisition cost of a brand-name drug by more than 20% per pricing unit, increased the wholesale acquisition cost of a generic drug that costs at least $10 per pricing unit by more than 20 % per pricing unit or introduced a new drug for distribution in this State when the wholesale acquisition cost is greater than the amount that would cause the drug to be considered a specialty drug under the Medicare Part D program. Prescription drug manufacturers, wholesale drug distributors and pharmacy benefits managers are also required to provide pricing component data per pricing unit of a drug within 60 days of a request by the Maine Health Data Organization. This rule defines “pricing component data” as data unique to each manufacturer, wholesale drug distributor or pharmacy benefit manager that evidences the cost to make a prescription drug available to consumers and the payments received by each manufacturer, wholesale drug distributor or pharmacy benefit manager to make a prescription drug available to consumers, taking into account any price concessions, that is measured uniformly among and between the entities. A public hearing will be held 11/21/19 at 9:00am at the MHDO and the deadline for public comments is 12/2/19 at 5:00 pm. October 30, 2019 - Proposed Rule Chapter 100 - Enforcement Procedures Pursuant to PL 2019, c470, this proposed rule change adds prescription drug manufacturers, wholesale drug distributors and pharmacy benefits managers to the list of health care services entities who may be fined for failure to file prescription drug price data; failure to pay the annual assessment; and for intentional or knowing failure to protect the disclosure of confidential or privileged data. A public hearing will be held 11/21/19 at 9:00am at the MHDO and the deadline for public comments is 12/2/19 at 5:00 pm. October 30, 2019 - Proposed Rule Chapter 10 - Determination of Assessments Pursuant to PL 2019, c470, this proposed rule change adds prescription drug manufacturers, wholesale drug distributors and pharmacy benefits managers to the list of health care services entities required to pay annual assessments to support the operational costs of the Maine Health Data Organization. A public hearing will be held 11/21/19 at 9:00am at the MHDO and the deadline for public comments is 12/2/19 at 5:00 pm. October 30, 2019 - Proposed Rule Chapter 300 - Uniform Reporting System for Hospital Financial Data This proposed rule change will add the requirement that hospitals and parent entities be required to submit consolidated financial data along with organizational information. This change will provide greater transparency to the public into the finances of the hospital and parent entities. A public hearing will be held 11/21/19 at 9:00am at the MHDO and the deadline for public comments is 12/2/19 at 5:00 pm. July 2, 2019 - NEW – MHDO All-Payer Claims Database On-line Training Program To support interested and or new MHDO data users, the Maine Health Data Organization is pleased to release an online training program for Maine’s All Payer Claims Database (APCD). The training is designed in a modular format so that users can review sections most relevant to their needs. New modules will be added over time. For more information go to MHDO's All-Payer Claims Database On-line Training Program. March 2019 - New Report Public Law, Chapter 406, Section 2, requires the Maine Health Data Organization to develop a plan to collect data from manufacturers related to the cost and pricing of prescription drugs to provide transparency in and accountability for prescription drug pricing. The findings and recommendations of the Maine Health Data Organization are now available. February 2019 - The External Validation Report of CY 2017 Central Line-Associated Bloodstream Infection (CLABSI) in Maine Hospitals conducted on behalf of the Maine Quality Forum is now available January 24, 2019 - MHDO Briefed the Joint Standing Committee on Health and Human Services January 22, 2019 Here are the MQF and MHDO briefing documents. January 17, 2019 - MHDO Briefing to the Health Coverage, Insurance and Financial Services Committee Here are the MQF and MHDO briefing documents. December 27, 2017 - AHRQ Announces Release of a New HCUP Database - the 2015 Nationwide Emergency Department Sample (NEDS) The Agency for Healthcare Research and Quality (AHRQ) just released a new Healthcare Cost and Utilization Project (HCUP) database – ...